H syndrome

from Wikipedia, the free encyclopedia
Classification according to ICD-10
D76.3 Other histiocytosis syndromes
ICD-10 online (WHO version 2019)

The H-Syndrome , English histiocytosis-lymphadenopathy plus syndrome , is a very rare congenital form of systemic histiocytosis with the eponymous main features hyperpigmentation , hypertrichosis , hepatosplenomegaly , heart defects , hearing loss , hypogonadism and occasionally hyperglycaemia .

The following are added to this syndrome:

  • Pigmented hypertrichosis with insulin-dependent diabetes mellitus syndrome (PHID)
  • Faisalabad histiocytosis (FHC)
  • Familial sinus histiocytosis with massive lymphadenopathy (FSHML)

The name H syndrome was proposed in 2008 by the Israeli dermatologists V. Molho-Pessach and colleagues.

The disease should not be confused with HHH syndrome (triple H syndrome).

distribution

The frequency is given to be less than 1 in 1,000,000, so far about 100 patients have been reported. Inheritance is autosomal - recessive .

root cause

The disease are mutations in the SLC29A3 - gene on chromosome 10 locus Q22.2 based encoding the nucleoside transporter hENT3. The same gene is also involved in Rosai-Dorfman disease and dysosteosclerosis .

Clinical manifestations

Clinical criteria are:

diagnosis

The diagnosis arises from the characteristic skin changes and the combination of clinical features. The blood sedimentation is massively accelerated, there is a slight microcytic anemia in the blood serum , and increased liver values . The diagnosis is confirmed by genetic testing .

Differential diagnosis

To be distinguished are Torg-Winchester syndrome , hemochromatosis , POEMS syndrome and Rosai-Dorfman disease .

literature

  • M. Farooq, RM Moustafa, A. Fujimoto, H. Fujikawa, O. Abbas, AG Kibbi, M. Kurban, Y. Shimomura: Identification of two novel mutations in SLC29A3 encoding an equilibrative nucleoside transporter (hENT3) in two distinct Syrian families with H syndrome: expression studies of SLC29A3 (hENT3) in human skin. In: Dermatology. Vol. 224, No. 3, 2012, pp. 277-284, doi: 10.1159 / 000338886 , PMID 22653152 .
  • EA El-Khateeb: The H syndrome. In: Pediatric dermatology. Vol. 27, No. 1, 2010 Jan – Feb, pp. 65–68, doi: 10.1111 / j.1525-1470.2009.01076.x , PMID 20199414 (Review).

Individual evidence

  1. a b c d e f Orphanet
  2. H syndrome. In: Orphanet (Rare Disease Database).
  3. Hypertrichosis, pigmented, with insulin-dependent diabetes mellitus syndrome. In: Orphanet (Rare Disease Database).
  4. ^ Faisalabad histiocytosis. In: Orphanet (Rare Disease Database).
  5. Sinus histiocytosis, familial, with massive lymphadenopathy. In: Orphanet (Rare Disease Database).
  6. ^ V. Molho-Pessach, Z. Agha, S. Aamar, B. Glaser, V. Doviner, N. Hiller, DH Zangen, A. Raas-Rothschild, Z. Ben-Neriah, S. Shweiki, O. Elpeleg, A. Zlotogorski: The H syndrome: a genodermatosis characterized by indurated, hyperpigmented, and hypertrichotic skin with systemic manifestations. In: Journal of the American Academy of Dermatology. Vol. 59, No. 1, July 2008, pp. 79-85, doi: 10.1016 / j.jaad.2008.03.021 , PMID 18410979 .
  7. Histiocytosis-lymphadenopathy plus syndrome.  In: Online Mendelian Inheritance in Man . (English)

Web links